Your Resource for Cannabis Research

Your resource for cannabis research

Facilitating advances in cannabis research by providing resources and guidance to the scientific community

R3CR logo

Empowering Cannabis Research

Supporting researchers by offering regulatory clarity, quality standards, and a collaborative community to drive rigorous and reproducible cannabis studies.

Website and Social Media

Disseminate guidance and resources to the cannabis research community.

Workshops and Webinars

Educate researchers to generate rigorous scientific data.

Seed Funding

Support early career investigators and proposal development.

Regulatory Guidance

Compile and interpret policies to benefit researchers and agencies.

Analytical Procedures

Provide guidance on procedures for research materials.

Quality Standards

Improve reproducibility with guidance on standards and practices.

R3CR Tools for Cannabis Research

Materials for Research

Best Practices

  • Analytical Methodology
  • Quality of Research
  • Real-World Evidence

Regulatory Compliance

  • DEA Registration
  • FDA IND Information
  • Botanical Drug Research
  • Hemp Product Research

    Structure and Governance of R3CR

    This initiative is driven by a collaborative team spanning three institutions


    Washington State University logo

    Research Support Core

    Mary Paine, PI
    Rebecca Cooney
    Deena Hadi

    University of Mississippi logo

    Regulatory Guidance Core

    Ikhlas Khan, PI
    Mahmoud ElSohly, PI
    Robert Welch
    Donald Stanford

    US Pharmacopeia logo

    Research Standards Core

    Nandakumara Sarma, PI
    Amy Cadwallader
    Macy Ma

    Overall Impact of the R3CR

    The Resource Center for Cannabis and Cannabinoid Research (R3CR) is poised to make significant contributions across the cannabis research landscape. By leveraging the collective expertise of its partner institutions, the R3CR will:

    Advance cannabis research and regulatory processes by promoting studies aligned with NIH interests and providing clarity that encourages pharmaceutical innovation and quality production of research materials.

    Streamline regulatory pathways for researchers and agencies, offering guidance and tools that improve compliance, reduce errors in applications, and expedite the review of cannabis-related studies.

    Generate critical data and resources to support informed decisions, benefiting the FDA’s evaluation of cannabis in various products and enhancing the NIDA Drug Supply Program’s ability to meet evolving research needs.